Name | MC-1-F2 |
---|
Description | MC-1-F2 is a FOXC2 inhibitor that reduces epithelial-mesenchymal transition (EMT) markers in breast cancer cells, suppresses cancer stem cell (CSC) properties and reduces invasiveness in castration-resistant prostate cancer (CRPC) cells. There is a synergistic effect between MC-1-F2 and Docetaxel, which has the potential to be used in combination to study CRPC[1]. |
---|---|
Related Catalog | |
Target |
FOXC2[1]. |
References |
Molecular Formula | C37H46N16O2 |
---|---|
Molecular Weight | 746.87 |